US4801726A
(en)
|
1986-04-15 |
1989-01-31 |
Northeastern University |
Repetitive hit-and-run immunoassay and stable support-analyte conjugates; applied to T-2 toxin
|
US5190864A
(en)
|
1986-04-15 |
1993-03-02 |
Northeastern University |
Enzyme amplification by using free enzyme to release enzyme from an immobilized enzyme material
|
US4937188A
(en)
|
1986-04-15 |
1990-06-26 |
Northeastern University |
Enzyme activity amplification method for increasing assay sensitivity
|
JPH07111423B2
(ja)
*
|
1986-10-01 |
1995-11-29 |
株式会社日立製作所 |
クロマトグラフのデ−タ処理方法
|
JPS6486060A
(en)
*
|
1987-09-29 |
1989-03-30 |
Shimadzu Corp |
Analysis data processor
|
US5412083A
(en)
|
1992-04-16 |
1995-05-02 |
Northeastern University |
Carbohydrate heterobifunctional cross-linking reagent
|
US5429746A
(en)
|
1994-02-22 |
1995-07-04 |
Smith Kline Beecham Corporation |
Antibody purification
|
WO1996025425A1
(en)
|
1995-02-16 |
1996-08-22 |
Massachusetts Health Research Institute, Inc. |
Purified tetanus toxoid and toxin
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
JP3180010B2
(ja)
*
|
1995-10-13 |
2001-06-25 |
株式会社日立製作所 |
クロマトグラフ分析装置
|
KR19990056559A
(ko)
*
|
1997-12-29 |
1999-07-15 |
윤종용 |
노이즈 감소방법 및 그 장치
|
EP0964057B1
(en)
|
1998-05-11 |
2004-12-22 |
Tosoh Corporation |
Method for separating nucleic acids by means of liquid chromatography
|
US7306799B2
(en)
|
1999-06-08 |
2007-12-11 |
Regeneron Pharmaceuticals, Inc. |
Use of VEGF inhibitors for treatment of eye disorders
|
US7303746B2
(en)
|
1999-06-08 |
2007-12-04 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating eye disorders with modified chimeric polypeptides
|
US7087411B2
(en)
|
1999-06-08 |
2006-08-08 |
Regeneron Pharmaceuticals, Inc. |
Fusion protein capable of binding VEGF
|
US7070959B1
(en)
|
1999-06-08 |
2006-07-04 |
Regeneron Pharmaceuticals, Inc. |
Modified chimeric polypeptides with improved pharmacokinetic properties
|
JP4340062B2
(ja)
|
2000-10-12 |
2009-10-07 |
ジェネンテック・インコーポレーテッド |
粘度の減少した濃縮タンパク質製剤
|
US20020064860A1
(en)
|
2000-11-29 |
2002-05-30 |
Schering Corporation |
Method for purifying adenoviruses
|
US7101982B2
(en)
|
2001-03-30 |
2006-09-05 |
Immunex Corporation |
Control of ph transitions during chromatography
|
EP1585964A4
(en)
|
2002-08-28 |
2008-07-16 |
Introgen Therapeutics Inc |
CHROMATOGRAPHIC METHODS FOR PURIFYING ADENOVIRUSES
|
EP1545574B8
(en)
|
2002-09-13 |
2014-09-24 |
Biogen Idec Inc. |
Method of purifying polypeptides by simulated moving bed chromatography
|
US20060257972A1
(en)
|
2003-03-31 |
2006-11-16 |
Takashi Ishihara |
Purification of human monoclonal antibody and human polyclonal antibody
|
EP1641827A2
(en)
|
2003-06-27 |
2006-04-05 |
Biogen Idec MA Inc. |
Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions
|
ES2342539T3
(es)
|
2003-10-24 |
2010-07-08 |
Amgen, Inc. |
Proceso para la purificacion de proteinas en una fraccion de flujo-directo de cromatografia de interaccion hidrofobica.
|
US8084032B2
(en)
|
2004-01-21 |
2011-12-27 |
Ajinomoto Co., Inc. |
Purification method which prevents denaturation of an antibody
|
JP4848356B2
(ja)
|
2004-02-27 |
2011-12-28 |
ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ |
抗体精製法
|
SE0400501D0
(sv)
|
2004-02-27 |
2004-02-27 |
Amersham Biosciences Ab |
Antibody purification
|
SE0400886D0
(sv)
|
2004-04-02 |
2004-04-02 |
Amersham Biosciences Ab |
Process of purification
|
US7795405B2
(en)
|
2004-08-09 |
2010-09-14 |
Guild Associates, Inc. |
Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis
|
WO2006020622A1
(en)
|
2004-08-09 |
2006-02-23 |
Guild Associates, Inc. |
Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis
|
CA2583578C
(en)
|
2004-10-21 |
2014-04-01 |
Ge Healthcare Bio-Sciences Ab |
Chromatography ligand
|
WO2006088650A2
(en)
|
2005-02-02 |
2006-08-24 |
Regeneron Pharmaceuticals, Inc. |
Method of treating eye injury with local administration of a vegf inhibitor
|
WO2007064281A1
(en)
|
2005-12-02 |
2007-06-07 |
Ge Healthcare Bio-Sciences Ab |
Hydrophobic interaction chromatography
|
CN101410137A
(zh)
|
2006-03-28 |
2009-04-15 |
霍夫曼-拉罗奇有限公司 |
抗-igf-1r人单克隆抗体制剂
|
EP2738178A1
(en)
|
2006-04-05 |
2014-06-04 |
AbbVie Biotechnology Ltd |
Antibody purification
|
PL2944306T3
(pl)
|
2006-06-16 |
2021-07-12 |
Regeneron Pharmaceuticals, Inc. |
Postacie użytkowe antagonisty VEGF odpowiednie do podawania do ciała szklistego
|
US9766217B2
(en)
|
2006-09-08 |
2017-09-19 |
Novo Nordisk A/S |
Methods of optimizing chromatographic separation of polypeptides
|
US8969532B2
(en)
|
2006-10-03 |
2015-03-03 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
|
US20080299545A1
(en)
|
2007-03-06 |
2008-12-04 |
Shuyuan Zhang |
Chromatographic methods for assessing adenovirus purity
|
US8003364B2
(en)
|
2007-05-14 |
2011-08-23 |
Bavarian Nordic A/S |
Purification of vaccinia viruses using hydrophobic interaction chromatography
|
WO2009058769A1
(en)
|
2007-10-30 |
2009-05-07 |
Schering Corporation |
Purification of antibodies containing hydrophobic variants
|
DK2252952T3
(da)
*
|
2008-01-25 |
2019-06-11 |
Biogen Ma Inc |
Automatiseret system og fremgangsmåde til monitorering af ydeevnen for en kromatografisøjle samt anvendelser deraf
|
US7897405B2
(en)
*
|
2008-02-11 |
2011-03-01 |
Thermo Finnigan Llc |
Method for identifying the elution time of an analyte
|
US20090277254A1
(en)
|
2008-05-09 |
2009-11-12 |
Medlmmune, Llc |
Methods of improving packed-bed chromatography performance
|
US8410928B2
(en)
*
|
2008-08-15 |
2013-04-02 |
Biogen Idec Ma Inc. |
Systems and methods for evaluating chromatography column performance
|
US20100069617A1
(en)
|
2008-09-12 |
2010-03-18 |
Ge Healthcare Bio-Sciences Ab |
Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions
|
SG195577A1
(en)
|
2008-10-20 |
2013-12-30 |
Abbott Lab |
Viral inactivation during purification of antibodies
|
CN102257006A
(zh)
|
2008-10-20 |
2011-11-23 |
雅培制药有限公司 |
使用a蛋白亲和层析分离和纯化抗体
|
SG175188A1
(en)
|
2009-05-04 |
2011-11-28 |
Abbott Biotech Ltd |
Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
|
HUE028341T2
(en)
|
2009-06-16 |
2016-12-28 |
Genzyme Corp |
Improved methods for purification of recombinant aav vectors
|
WO2011028961A2
(en)
|
2009-09-04 |
2011-03-10 |
Xoma Technology Ltd. |
Anti-botulism antibody coformulations
|
US8491904B2
(en)
|
2009-10-20 |
2013-07-23 |
Abbvie Inc. |
Isolation and purification of anti-IL-13 antibodies using protein A affinity chromatography
|
US8246833B2
(en)
|
2009-12-17 |
2012-08-21 |
Ge Healthcare Bio-Sciences Ab |
Chromatography column and maintenance method
|
KR20120118065A
(ko)
|
2010-02-12 |
2012-10-25 |
디에스엠 아이피 어셋츠 비.브이. |
단일 단위체 항체 정제
|
CN102906851B
(zh)
*
|
2010-06-10 |
2015-09-16 |
国际商业机器公司 |
分析质谱的方法及系统
|
WO2012030512A1
(en)
|
2010-09-03 |
2012-03-08 |
Percivia Llc. |
Flow-through protein purification process
|
US8821865B2
(en)
|
2010-11-11 |
2014-09-02 |
Abbvie Biotechnology Ltd. |
High concentration anti-TNFα antibody liquid formulations
|
EP2652491B1
(en)
|
2010-12-15 |
2017-11-29 |
Baxalta GmbH |
Eluate collection using conductivity gradient
|
HUP1100312A2
(en)
*
|
2011-06-14 |
2013-01-28 |
Emil Dr Mincsovics |
Procedure and equipment for improving of performance characteristics of column chromatography separation processes
|
US9943594B2
(en)
|
2011-10-11 |
2018-04-17 |
Sanofi Biotechnology |
Methods for the treatment of rheumatoid arthritis
|
TWI589299B
(zh)
|
2011-10-11 |
2017-07-01 |
再生元醫藥公司 |
用於治療類風濕性關節炎之組成物及其使用方法
|
EP2773439A4
(en)
|
2011-10-31 |
2015-07-01 |
Merck Sharp & Dohme |
CHROMATOGRAPHY METHOD FOR RESOLVING HETEROGENIC ANTIBODY AGGREGATES
|
AU2012339722B2
(en)
|
2011-11-14 |
2017-09-14 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and/or Activin A
|
AU2012340826A1
(en)
|
2011-11-21 |
2014-05-29 |
Genentech, Inc. |
Purification of anti-c-met antibodies
|
KR101498771B1
(ko)
|
2011-12-15 |
2015-03-09 |
한화케미칼 주식회사 |
항체의 정제 방법
|
JP6077568B2
(ja)
*
|
2012-01-16 |
2017-02-08 |
レコ コーポレイションLeco Corporation |
クロマトグラフィーシステムでのデータを処理するためのシステム及び方法
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
US9150645B2
(en)
|
2012-04-20 |
2015-10-06 |
Abbvie, Inc. |
Cell culture methods to reduce acidic species
|
US9181572B2
(en)
|
2012-04-20 |
2015-11-10 |
Abbvie, Inc. |
Methods to modulate lysine variant distribution
|
US20140154270A1
(en)
|
2012-05-21 |
2014-06-05 |
Chen Wang |
Purification of non-human antibodies using kosmotropic salt enhanced protein a affinity chromatography
|
US20140010820A1
(en)
|
2012-05-21 |
2014-01-09 |
Abbvie, Inc. |
Novel purification of non-human antibodies using protein a affinity chromatography
|
US9249182B2
(en)
|
2012-05-24 |
2016-02-02 |
Abbvie, Inc. |
Purification of antibodies using hydrophobic interaction chromatography
|
US8941405B2
(en)
|
2012-08-03 |
2015-01-27 |
International Business Machines Corporation |
FET pair based physically unclonable function (PUF) circuit with a constant common mode voltage
|
WO2014025771A2
(en)
|
2012-08-06 |
2014-02-13 |
Biogen Idec Ma Inc. |
Methods and compositions for inactivating enveloped viruses
|
US9650411B2
(en)
|
2012-08-07 |
2017-05-16 |
Kyowa Hakko Kirin Co., Ltd. |
Method of purifying protein
|
AU2013361587A1
(en)
|
2012-12-20 |
2015-06-18 |
Medimmune, Llc |
Liquid antibody formulation with improved aggregation properties
|
MX2015012114A
(es)
|
2013-03-08 |
2016-01-12 |
Genzyme Corp |
Fabricacion continua integrada de principios activos proteinicos terapeuticos.
|
WO2014143205A1
(en)
|
2013-03-12 |
2014-09-18 |
Abbvie Inc. |
Human antibodies that bind human tnf-alpha and methods of preparing the same
|
US10023608B1
(en)
|
2013-03-13 |
2018-07-17 |
Amgen Inc. |
Protein purification methods to remove impurities
|
KR20150129033A
(ko)
|
2013-03-14 |
2015-11-18 |
애브비 인코포레이티드 |
저 산성 종 조성물 및 이의 제조 및 사용 방법
|
US9017687B1
(en)
|
2013-10-18 |
2015-04-28 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same using displacement chromatography
|
JP6592426B2
(ja)
|
2013-03-15 |
2019-10-16 |
バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. |
無塩条件下で疎水性相互作用クロマトグラフィーを使用するタンパク質精製
|
AR095615A1
(es)
|
2013-03-15 |
2015-10-28 |
Alder Biopharmaceuticals Inc |
Purificación de anticuerpos y monitoreo de pureza
|
PT2981822T
(pt)
|
2013-05-06 |
2020-12-07 |
Scholar Rock Inc |
Composições e métodos para modulação do fator de crescimento
|
US10111953B2
(en)
|
2013-05-30 |
2018-10-30 |
Regeneron Pharmaceuticals, Inc. |
Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
|
TWI682780B
(zh)
|
2013-05-30 |
2020-01-21 |
美商再生元醫藥公司 |
醫藥組成物用於製造治療與pcsk9功能獲得性突變有關之體染色體顯性高膽固醇血症的藥物之用途
|
TWI633891B
(zh)
|
2013-06-04 |
2018-09-01 |
再生元醫藥公司 |
藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法
|
KR101569783B1
(ko)
|
2013-06-05 |
2015-11-19 |
한화케미칼 주식회사 |
항체의 정제 방법
|
US9150938B2
(en)
|
2013-06-12 |
2015-10-06 |
Orochem Technologies, Inc. |
Tagatose production from deproteinized whey and purification by continuous chromatography
|
TWI596107B
(zh)
|
2013-06-25 |
2017-08-21 |
卡地拉保健有限公司 |
單株抗體之新穎純化方法
|
US20150093800A1
(en)
|
2013-09-05 |
2015-04-02 |
Genentech, Inc. |
Method for chromatography reuse
|
AU2014318615B2
(en)
|
2013-09-13 |
2020-03-12 |
Genentech, Inc. |
Methods and compositions comprising purified recombinant polypeptides
|
JP6546178B2
(ja)
|
2013-09-13 |
2019-07-17 |
ジェネンテック, インコーポレイテッド |
細胞株中の宿主細胞タンパク質及び組換えポリペプチド産物を検出及び定量化するための組成物並びに方法
|
US8946395B1
(en)
|
2013-10-18 |
2015-02-03 |
Abbvie Inc. |
Purification of proteins using hydrophobic interaction chromatography
|
US20160251441A1
(en)
|
2013-10-25 |
2016-09-01 |
Medimmune, Llc |
Antibody purification
|
US10115576B2
(en)
*
|
2013-12-12 |
2018-10-30 |
Waters Technologies Corporation |
Method and an apparatus for analyzing a complex sample
|
CN103616458B
(zh)
*
|
2013-12-14 |
2015-05-27 |
环境保护部南京环境科学研究所 |
一种定量检测大气细粒子pm2.5中6种硝基苯类化合物的方法
|
JP6260351B2
(ja)
*
|
2014-03-04 |
2018-01-17 |
株式会社島津製作所 |
クロマトグラフ用データ処理装置及びデータ処理方法
|
JO3701B1
(ar)
|
2014-05-23 |
2021-01-31 |
Regeneron Pharma |
مضادات حيوية بشرية لمتلازمة الشرق الأوسط التنفسية - بروتين كورونا فيروس الشوكي
|
FR3025515B1
(fr)
|
2014-09-05 |
2016-09-09 |
Lab Francais Du Fractionnement |
Procede de purification d'un anticorps monoclonal
|
TW201628649A
(zh)
|
2014-10-09 |
2016-08-16 |
再生元醫藥公司 |
減少醫藥調配物中微可見顆粒之方法
|
EP3226899A4
(en)
|
2014-12-02 |
2018-09-05 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating dry eye disease by administering an il-6r antagonist
|
WO2016118707A1
(en)
|
2015-01-21 |
2016-07-28 |
Oncobiologics, Inc. |
Modulation of charge variants in a monoclonal antibody composition
|
TWI710573B
(zh)
|
2015-01-26 |
2020-11-21 |
美商再生元醫藥公司 |
抗伊波拉病毒醣蛋白之人類抗體
|
CN104748764B
(zh)
*
|
2015-04-01 |
2017-05-24 |
清华大学 |
一种声场可视化系统中声像平面的空间角度标定方法
|
TWI756187B
(zh)
|
2015-10-09 |
2022-03-01 |
美商再生元醫藥公司 |
抗lag3抗體及其用途
|
MA44145A
(fr)
|
2015-12-22 |
2018-10-31 |
Regeneron Pharma |
Anticorps anti-cd20/anti-cd3 bispécifiques pour traiter la leucémie aiguë lymphoblastique
|
FI3394103T3
(fi)
|
2015-12-22 |
2023-08-30 |
Regeneron Pharma |
Anti-PD-1-vasta-aineiden ja bispesifisten anti-CD20-/anti-CD3-vasta-aineiden yhdistelmä syövän hoitoon
|
EP3184119A1
(en)
|
2015-12-23 |
2017-06-28 |
Themis Bioscience GmbH |
Chromatography based purification strategies for measles scaffold based viruses
|
GB201602938D0
(en)
|
2016-02-19 |
2016-04-06 |
Ucb Biopharma Sprl |
Protein purification
|
US10353868B2
(en)
*
|
2016-04-11 |
2019-07-16 |
RMC Pharmaceutical Solutions, Inc. |
Methods and systems for event based notifications
|
CN109641928B
(zh)
|
2016-06-14 |
2022-08-30 |
比奥根Ma公司 |
用于寡核苷酸纯化的疏水性相互作用色谱法
|
WO2018027195A1
(en)
|
2016-08-05 |
2018-02-08 |
Abbvie Biotherapeutics Inc. |
Compositions containing reduced amounts of daclizumab acidic isoforms and methods for preparing the same
|
AU2017350807B2
(en)
*
|
2016-10-25 |
2022-07-07 |
Regeneron Pharmaceuticals, Inc. |
Methods and systems for chromatography data analysis
|
US10626376B2
(en)
|
2016-11-14 |
2020-04-21 |
St. Jude Children's Research Hospital |
Method for isolating and purifying adeno-associated virus particles using salt
|
EP3672981A4
(en)
|
2017-08-22 |
2021-09-15 |
Biogen MA Inc. |
PROCESSES FOR PURIFYING ANTIBODIES PRESENTING REDUCED AGGREGATES WITH HIGH MOLECULAR WEIGHT
|
US12325875B2
(en)
|
2018-03-16 |
2025-06-10 |
Bristol-Myers Squibb Company |
Metabolic enzyme activity and disulfide bond reduction during protein production
|
WO2019178495A1
(en)
|
2018-03-16 |
2019-09-19 |
Biogen Ma Inc. |
Methods for purifying recombinant adeno-associated viruses
|
CN112313248A
(zh)
|
2018-03-29 |
2021-02-02 |
百时美施贵宝公司 |
纯化单体单克隆抗体的方法
|
CN112566930A
(zh)
|
2018-06-19 |
2021-03-26 |
百时美施贵宝公司 |
使用色谱纯化蛋白质的方法
|
TW202448568A
(zh)
|
2018-07-02 |
2024-12-16 |
美商里珍納龍藥品有限公司 |
自混合物製備多肽之系統及方法
|
US20220267369A1
(en)
|
2018-07-25 |
2022-08-25 |
Merck Sharp & Dohme Corp. |
Methods of separating host cell lipases from a production protein in chromatographic processes
|
EP3837281A1
(en)
|
2018-08-15 |
2021-06-23 |
Bristol-Myers Squibb Company |
Protein fragmentation control strategy by re-oxidation in downstream chromatography
|
KR20210090649A
(ko)
|
2018-11-05 |
2021-07-20 |
브리스톨-마이어스 스큅 컴퍼니 |
Peg화 단백질의 정제 방법
|
WO2020172658A1
(en)
|
2019-02-24 |
2020-08-27 |
Bristol-Myers Squibb Company |
Methods of isolating a protein
|
US12174161B2
(en)
|
2019-03-29 |
2024-12-24 |
Bristol-Myers Squibb Company |
Methods of measuring hydrophobicity of chromatographic resins
|
JP7539420B2
(ja)
|
2019-06-28 |
2024-08-23 |
武田薬品工業株式会社 |
アデノ随伴ウイルスの精製方法
|